GLP-1 Weight Loss Guide

GLP-1 Medications for Weight Loss

GLP-1 (Glucagon-Like Peptide-1) receptor agonists are prescription medications that have become central to medical weight management. This is general education; GLP3 Weight Loss does not prescribe, dispense, or treat. Only an independent licensed provider can prescribe.

How GLP-1 Works

  • Appetite Suppression: Reduces hunger signals in the brain
  • Gastric Emptying: Slows digestion so you feel full longer
  • Blood Sugar Regulation: Improves insulin sensitivity
  • Cardiovascular Benefits: Reduced cardiovascular events reported in trials

The Medications

Semaglutide (Ozempic/Wegovy) — Once-weekly injection. FDA-approved for weight management. Trials reported roughly 15% average weight loss.

Tirzepatide (Mounjaro/Zepbound) — Dual GLP-1/GIP agonist. FDA-approved for weight management. Trials reported roughly 21% average weight loss.

These figures describe what researchers reported in trials, not results we offer. Compare the medications →

Medical References

Content on this page is informational only and not a substitute for professional medical advice. Always consult a qualified healthcare provider about your individual condition. Key sources:

  1. NIH / NIDDK: Prescription Medications to Treat Overweight & Obesity
  2. FDA: Wegovy (semaglutide) approval announcement
  3. FDA: Zepbound (tirzepatide) approval announcement